
How Pharmacogenomics Deliver More Precise Cancer Therapy
From Answers from the Lab by Mayo Clinic Laboratories
June 11, 2026 · 21 min · Episode 385
About this episode
This episode discusses updates on clinical diagnostics policies and how pharmacogenomics are enhancing cancer treatment precision.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D. , president and CEO of Mayo Clinic Laboratories, to discuss updates on the Protecting Access to Medicare Act (PAMA) and other policy changes affecting clinical diagnostics. Later, Dr. Pritt welcomes Ann Moyer, M.D., Ph.D. , a molecular genetic pathologist at Mayo Clinic and chair of the hereditary genetics practice, to explore how precision therapeutics are improving cancer treatments. PAMA update (00:01): Get the latest on PAMA as the first data collection period begins, including ongoing efforts to advance the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Policy changes influencing diagnostics (04:09) : Learn how evolving reimbursement policies for blood-based cancer screening and a proposed CLIA modernization bill may impact the field. Pharmacogenomic tests improving cancer care (08:14) : Discover how pharmacogenomics are benefiting patients with cancer, the benefits of medication-based testing, and how this field is advancing. Resources CMS: CLFS & PAMA…
People in this episode
Host: Bobbi Pritt, M.D.
Guests: William Morice II, M.D., Ph.D., Ann Moyer, M.D., Ph.D.
Topics covered
- pharmacogenomics
- cancer therapy
- clinical diagnostics
- policy changes
- precision therapeutics
- medicare act
Keywords
- pharmacogenomics
- cancer treatment
- clinical diagnostics
- medicare
- precision medicine
- blood-based cancer screening
- genetic testing
Mentioned in this episode
Organizations: Mayo Clinic, Mayo Clinic Laboratories, Protecting Access to Medicare Act (PAMA), Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, CLIA, CMS, Precision Oncology Therapeutics
More episodes of Answers from the Lab
- Risks Increase as Ticks, Mosquitoes, and Similar Vectors Spread · May 28, 2026 · 23 min
- Lab Stewardship in Modern Healthcare · May 14, 2026 · 16 min
- Unique Assays Advance Care of Complex Autoimmune Skin Conditions · April 23, 2026 · 17 min
- Digital Advances: What’s Next for Clinical Diagnostics? · April 9, 2026 · 26 min
- Preeclampsia Test Helps Extend Pregnancy to Improve Outcomes · March 19, 2026 · 18 min
- Breakthrough Test Enhances Peripheral Neuropathy Care and Research · March 5, 2026 · 17 min
Explore listener stats, chart rankings, contacts and more on the Answers from the Lab podcast page.